CoChat

Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice

Open access
Xue, Yansong, Zhang, Hanying, Sun, Xiaofei, Zhu, Mei-Jun · 2016 · PLOS ONE

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS: The impairment of intestinal epithelial barrier is the main etiologic factor of inflammatory bowel disease. The proper intestinal epithelial proliferation and differentiation is crucial for maintaining intestinal integrity. Metformin is a common anti-diabetic drug. The objective is to evaluate the protective effects of metformin on ileal epithelial barrier integrity using interleukin-10 deficient (IL10KO) mice. METHODS: Wild-type and IL10KO mice were fed with/without metformin for 6 weeks and then ileum was collected for analyses. The mediatory role of AMP-activated protein kinase (AMPK) was further examined by gain and loss of function study in vitro. RESULTS: Compared to wild-type mice, IL10KO mice had increased proliferation, reduced goblet cell and Paneth cell lineage differentiation in the ileum tissue, which was accompanied with increased crypt expansion. Metformin supplementation mitigated intestinal cell proliferation, restored villus/crypt ratio, increased goblet cell and Paneth cell differentiation and improved barrier function. In addition, metformin supplementation in IL10KO mice suppressed macrophage pro-inflammatory activity as indicated by reduced M1 macrophage abundance and decreased pro-inflammatory cytokine IL-1β, TNF-α and IFN-γ expressions. As a target of metformin, AMPK phosphorylation was enhanced in mice treated with metformin, regardless of mouse genotypes. In correlation, the mRNA level of differentiation regulator including bmp4, bmpr2 and math1 were also increased in IL10KO mice supplemented with metformin, which likely explains the enhanced epithelial differentiation in IL10KO mice with metformin. Consistently, in Caco-2 cells, metformin promoted claudin-3 and E-cadherin assembly and mitigated TNF-α-induced fragmentation of tight junction proteins. Gain and loss of function assay also demonstrated AMPK was correlated with epithelial differentiation and proliferation. CONCLUSIONS: Metformin supplementation promotes secretory cell lineage differentiation, suppresses inflammation and improves epithelial barrier function in IL10KO mice likely through activation of AMPK, showing its beneficial effects on gut epithelial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0168670

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Metformin improves intestinal epithelial barrier function in vivo and in vitro. (A) Weekly body weight; (B) Daily feed intake; (C) In vivo intestinal permeability assay; (D) The mRNA levels of tight junction proteins in mouse ileum tissues; (E) Immunoblotting of claudin-3 and E-cadherin in mouse ileum tissues; (F) Immunoblotting of E-cadherin in Caco-2 cells treated with or without metformin. (G) Immunofluorescent staining of claudin-3 and E-cadherin in Caco-2 cells with calcium switch. The cells were subjected to calcium depletion for 30 min followed by incubation in complete medium for 12 h supplemented with or without 1mM metformin. EGTA: Caco-2 cells with calcium depletion; Con: Caco-2 cells were Ca2+ restored and treated without metformin; Metformin: Caco-2 cells were Ca2+ restored and treated with metformin. Scale bar is 100μm. (*: P < 0.05; **: P < 0.01; means ± SEM, n = 10).
Fig 1 Metformin improves intestinal epithelial barrier function in vivo and in vitro. (A) Weekly body weight; (B) Daily feed intake; (C) In vivo intestinal permeability assay; (D) The mRNA levels of tight junction proteins in mouse ileum tissues; (E) Immunoblotting of claudin-3 and E-cadherin in mouse ileum tissues; (F) Immunoblotting of E-cadherin in Caco-2 cells treated with or without metformin. (G) Immunofluorescent staining of claudin-3 and E-cadherin in Caco-2 cells with calcium switch. The cells were subjected to calcium depletion for 30 min followed by incubation in complete medium for 12 h supplemented with or without 1mM metformin. EGTA: Caco-2 cells with calcium depletion; Con: Caco-2 cells were Ca2+ restored and treated without metformin; Metformin: Caco-2 cells were Ca2+ restored and treated with metformin. Scale bar is 100μm. (*: P < 0.05; **: P < 0.01; means ± SEM, n = 10).CC BY · PubMed Central
Fig 2 Inflammatory response in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) Inflammatory cytokine mRNA expression; (B) and (C) M1 macrophage IHC staining; (D) Immunofluorescent staining of claudin-3 and E-cadherin in Caco-2 cells treated with TNF-α and with/without co-incubation with metformin for 24 h. Con: Caco-2 cells without treatment; TNF-α: Caco-2 cells treated with 10ng/ml TNF-α; TNF-α + Metformin: Caco-2 cells treated with 10ng/ml TNF-α and 1mM metformin. Scale bar is 100μm. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).
Fig 2 Inflammatory response in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) Inflammatory cytokine mRNA expression; (B) and (C) M1 macrophage IHC staining; (D) Immunofluorescent staining of claudin-3 and E-cadherin in Caco-2 cells treated with TNF-α and with/without co-incubation with metformin for 24 h. Con: Caco-2 cells without treatment; TNF-α: Caco-2 cells treated with 10ng/ml TNF-α; TNF-α + Metformin: Caco-2 cells treated with 10ng/ml TNF-α and 1mM metformin. Scale bar is 100μm. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).CC BY · PubMed Central
Fig 3 Morphological alteration and epithelial proliferation markers in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) Ileum morphological analysis; (B) Proliferative cells identified by Ki67 IHC staining; (C) and (D) Proliferative cells identified by BrdU incorporation. Images were taken at 200× magnification. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).
Fig 3 Morphological alteration and epithelial proliferation markers in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) Ileum morphological analysis; (B) Proliferative cells identified by Ki67 IHC staining; (C) and (D) Proliferative cells identified by BrdU incorporation. Images were taken at 200× magnification. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).CC BY · PubMed Central
Fig 4 IHC staining for Paneth cell and goblet cell in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) and (B) Lysozyme positive Paneth cells; (C) and (D) Goblet cell density. Images were taken at 200× magnification. (*: P < 0.05; **: P < 0.01; means ± SEM; n = 10).
Fig 4 IHC staining for Paneth cell and goblet cell in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) and (B) Lysozyme positive Paneth cells; (C) and (D) Goblet cell density. Images were taken at 200× magnification. (*: P < 0.05; **: P < 0.01; means ± SEM; n = 10).CC BY · PubMed Central
Fig 5 AMPK signaling in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) AMPK and p-AMPK analyzed by immunoblotting. (B) AMP and ATP content in ileum tissues analyzed by HPLC. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).
Fig 5 AMPK signaling in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) AMPK and p-AMPK analyzed by immunoblotting. (B) AMP and ATP content in ileum tissues analyzed by HPLC. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).CC BY · PubMed Central
Fig 6 mRNA expression of key mediators of BMP signaling and transcription factors regulating epithelial differentiation in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) bmp2; (B) bmp4; (C) bmpr2; D. math1. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).
Fig 6 mRNA expression of key mediators of BMP signaling and transcription factors regulating epithelial differentiation in IL10KO or WT mice supplemented with (■, MET) or without (□, CON) metformin. (A) bmp2; (B) bmp4; (C) bmpr2; D. math1. (#: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 10).CC BY · PubMed Central
Fig 7 AMPK is associated with the mediators of intestinal epithelial cell differentiation and proliferation in vitro. Caco-2 cells were transfected with plasmid constructs over-expressing green fluorescent protein (EGFP) (CON), wild-type AMPK (WT) or dominant negative AMPK (K45R), and harvested for mRNA and protein measurement 4 days later. (A) Immunoblotting of p-ACC, p-Smad1/5/8 and PCNA; Left panel showed the representative bands of western blotting; Right panel showed the statistical analysis for each transfected clone. (B) mRNA expression of math1, bmp2, bmp4 and bmpr2. #: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 4).
Fig 7 AMPK is associated with the mediators of intestinal epithelial cell differentiation and proliferation in vitro. Caco-2 cells were transfected with plasmid constructs over-expressing green fluorescent protein (EGFP) (CON), wild-type AMPK (WT) or dominant negative AMPK (K45R), and harvested for mRNA and protein measurement 4 days later. (A) Immunoblotting of p-ACC, p-Smad1/5/8 and PCNA; Left panel showed the representative bands of western blotting; Right panel showed the statistical analysis for each transfected clone. (B) mRNA expression of math1, bmp2, bmp4 and bmpr2. #: P < 0.1; *: P < 0.05; **: P < 0.01; means ± SEM; n = 4).CC BY · PubMed Central
Fig 8 Model for effects of metformin on ileal epithelial barrier function. (A) Metformin supplementation induce differentiation of goblet cells and Paneth cells through the activation of AMPK-mediated BMP signaling pathway. The differentiated cells secrete mucins and anti-microbial components that compose the mucus layer (indicated as big blue dots), which enhances epithelial barrier function and thus defense against foreign antigens (indicated as red solid ovals) (B) Chronic inflammation induced by activated pro-inflammatory macrophages destructs epithelial integrity and causes intestinal epithelial abnormal proliferation. Metformin supplementation attenuates chronic inflammatory response and restores barrier function through the activation of AMPK.
Fig 8 Model for effects of metformin on ileal epithelial barrier function. (A) Metformin supplementation induce differentiation of goblet cells and Paneth cells through the activation of AMPK-mediated BMP signaling pathway. The differentiated cells secrete mucins and anti-microbial components that compose the mucus layer (indicated as big blue dots), which enhances epithelial barrier function and thus defense against foreign antigens (indicated as red solid ovals) (B) Chronic inflammation induced by activated pro-inflammatory macrophages destructs epithelial integrity and causes intestinal epithelial abnormal proliferation. Metformin supplementation attenuates chronic inflammatory response and restores barrier function through the activation of AMPK.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 70

Metadata

Authors
Xue, Y., Zhang, H., Sun, X., & Zhu, M.-J.
Affiliations
  • University of Idaho (US)
  • Washington State University (US)
Venue
PLOS ONE
Published
2016-12-21
Volume
11
Issue
12
Pages
e0168670
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2565774918
Cited by
61
References
68
Citations by year
2026: 2 · 2025: 7 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 7
FWCI
4.84
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Institutes of Health (R15HD073864)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
metformin, intestinal epithelial barrier, interleukin-10 deficiency, AMPK, goblet cell differentiation, Paneth cell differentiation, intestinal epithelial cell proliferation, macrophage polarization, tight junction proteins, BMP signaling, inflammatory bowel disease
MeSH terms
Animals, Cell Differentiation, Humans, Intestinal Mucosa, Macrophages, Metformin, Mice, Inbred C57BL, Permeability, Phosphorylation, Tumor Necrosis Factor-alpha, Cadherins, Cytokines, Interleukin-10, Mice, Knockout, Caco-2 Cells, Goblet Cells, Mice, Basic Helix-Loop-Helix Proteins, Bone Morphogenetic Protein Receptors, Type II, AMP-Activated Protein Kinases, Bone Morphogenetic Protein 4, Claudin-3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice. https://app.cochat.ai/papers/10.1371/journal.pone.0168670
The paper
Xue, Y., Zhang, H., Sun, X., & Zhu, M.-J. (2016). Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0168670

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.